| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/13/2013 | CA2858227A1 Robust controlled-release formulations |
| 06/13/2013 | CA2858211A1 Skin care formulation |
| 06/13/2013 | CA2858161A1 Medical organogel processes and compositions |
| 06/13/2013 | CA2857982A1 Robust controlled-release peptide formulations |
| 06/13/2013 | CA2857980A1 Dry powder formulation of azole derivative for inhalation |
| 06/13/2013 | CA2857189A1 Topical formulation for administering a compound |
| 06/13/2013 | CA2856043A1 Nasal formulation |
| 06/12/2013 | EP2601981A1 Absorbent polymeric compositions with varying counterion content and their methods of preparation and use |
| 06/12/2013 | EP2601974A1 Pharmaceutical preparation for controlling water-soluble drug release |
| 06/12/2013 | EP2601973A1 Dry powder formulation of azole derivative for inhalation |
| 06/12/2013 | EP2601972A2 Non-lithotripsic kidney-stone therapy |
| 06/12/2013 | EP2601971A1 Composition for regeneratng normal tissue from fibrotic tissue |
| 06/12/2013 | EP2601954A1 Therapeutic agent for disease |
| 06/12/2013 | EP2601948A1 Preparation for treatment of spinal cord injury |
| 06/12/2013 | EP2601947A1 Fixed-dose combination for treatment of helicobacter pylori associated diseases |
| 06/12/2013 | EP2601944A1 Transdermal patch and method for augmenting adhesive strength thereof |
| 06/12/2013 | EP2601939A2 Hydrogel compositions with an erodible backing member |
| 06/12/2013 | EP2601938A1 Pharmaceutical compositions for the treatment of Helicobacter pylori associated diseases |
| 06/12/2013 | EP2601937A1 Drinkable immediate release tablet made with direct compression of memantine or neramexane |
| 06/12/2013 | EP2601936A1 Compressed composition |
| 06/12/2013 | EP2601935A1 Compositions comprising lipophilic active compounds and method for their preparation |
| 06/12/2013 | EP2601934A1 Vesicular phospholipid gels comprising proteinaceous substances |
| 06/12/2013 | EP2601933A1 Hydrophilic filtration during manufacture of vaccine adjuvants |
| 06/12/2013 | EP2601932A1 Lyophilized recombinant VWF formulations |
| 06/12/2013 | EP2601262A1 A multicompartmentalized vesicular structure and a method for forming the same |
| 06/12/2013 | EP2601241A1 Absorbable peg-based hydrogels |
| 06/12/2013 | EP2600903A2 Preparation of extremely small and uniform sized, iron oxide-based paramagnetic or pseudo-paramagnetic nanoparticles and mri t1 contrast agents using the same |
| 06/12/2013 | EP2600881A1 Natural medicinal compound |
| 06/12/2013 | EP2600870A2 Pump systems and methods for storing and dispensing a plurality of precisely measured unit-doses of imiquimod cream |
| 06/12/2013 | EP2600864A2 Compositions and methods for treating inflammatory diseases |
| 06/12/2013 | EP2600852A2 Beclomethasone dipropionate compositions in modified-release gastro-resistant microspheres and process for obtaining them |
| 06/12/2013 | EP2600851A2 Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine for the treatment of neuropathic pain |
| 06/12/2013 | EP2600850A2 Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine for the treatment of nociceptive pain |
| 06/12/2013 | EP2600849A1 Film-forming composition for soft capsules |
| 06/12/2013 | EP2600848A1 Implantable drug delivery devices for genitourinary sites |
| 06/12/2013 | EP2600847A1 Oral pharmaceutical formulations of esomeprazole in the form of mups (multi unit pellets system) tablets |
| 06/12/2013 | EP2600846A2 Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cylohexane-1,1'-pyrano[3,4,b]indol]-4-amine |
| 06/12/2013 | EP2600845A2 Pharmaceutical composition containing a serenoa repens extract |
| 06/12/2013 | EP2600844A2 Interior functionalized hyperbranched dendron-conjugated nanoparticles and uses thereof |
| 06/12/2013 | EP2600843A2 Therapeutic protein compositions having reduced immunogenicity and/or improved efficacy |
| 06/12/2013 | EP2600842A1 Microparticle formulation for pulmonary drug delivery of anti-infective molecule for treatment of infectious diseases |
| 06/12/2013 | EP2600841A2 Pharmaceutical formulations of rasagiline |
| 06/12/2013 | EP2600840A2 Zeolites having a neuro-protective effect |
| 06/12/2013 | EP2600839A2 Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4,9'-dihydro-3'h-spiro[cylohexane-1,1'-pyrano[3,4,b]indol]-4-amine |
| 06/12/2013 | EP2600838A2 Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine |
| 06/12/2013 | EP2600837A1 Use of glyceryl trinitrate for treating hematomas |
| 06/12/2013 | EP2600836A1 Corticosteroids for the treatment of joint pain |
| 06/12/2013 | EP2600835A1 Combinations of hepatitis c virus inhibitors |
| 06/12/2013 | EP2600834A1 Collagen-based implants for sustained delivery of drugs |
| 06/12/2013 | EP2600833A2 Oral compositions comprising a zinc compound and an anti-microbial agent |
| 06/12/2013 | EP2600832A1 Combination of compounds for treating or preventing skin diseases |
| 06/12/2013 | EP2600831A2 Oral dosage form of pregabalin |
| 06/12/2013 | EP2600830A2 Dry powder formulation comprising a phosphodiesterase inhibitor |
| 06/12/2013 | EP2600829A2 Pharmaceutical formulation comprising a phosphodiesterase inhibitor |
| 06/12/2013 | EP2600792A1 Devices, systems, and methods for excavating cancer cells |
| 06/12/2013 | CN202982395U Elastic paster for bone joint inflammation |
| 06/12/2013 | CN1668305B Microbicidal pyrimidine or triazine for preventing sexual HIV transmission |
| 06/12/2013 | CN103153580A A process for producing a melt-extruded film, and melt-extruded film |
| 06/12/2013 | CN103153348A Preparation of extremely small and uniform sized, iron oxide-based paramagnetic or pseudo-paramagnetic nanoparticles and mri t1 contrast agents using the same |
| 06/12/2013 | CN103153343A Hydroxypropyl methyl cellulose acetate succinate with enhanced acetate and succinate substitution |
| 06/12/2013 | CN103153342A Nitric oxide delivery system using thermosensitive synthetic polymers |
| 06/12/2013 | CN103153320A Oral formulations for counteracting effects of aging |
| 06/12/2013 | CN103153317A Immunity inducer |
| 06/12/2013 | CN103153313A Compositions for treating heartworm infestation |
| 06/12/2013 | CN103153312A Piroxicam for prophylactically and therapeutically treating herpes infections |
| 06/12/2013 | CN103153306A Solid dispersion comprising triazole compound |
| 06/12/2013 | CN103153294A Transdermal patch and method for augmenting adhesive strength thereof |
| 06/12/2013 | CN103153290A Antimicrobial formulations that aid in wound healing |
| 06/12/2013 | CN103153289A Improved enteric active substance delivery |
| 06/12/2013 | CN103153288A Combination immediate/delayed release delivery system for short half-life pharmaceuticals including remogliflozin |
| 06/12/2013 | CN103153287A Pharmaceutical composition of (r)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxy propyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide and administration therof |
| 06/12/2013 | CN103153286A Pharmaceutical composition and administrations thereof |
| 06/12/2013 | CN103153285A Liposome composition and process for production thereof |
| 06/12/2013 | CN103153284A Liposomes with lipids having an advantageous pKa- value for RNA delivery |
| 06/12/2013 | CN103153283A Novel formulation of pegylated-liposome encapsulated glycopeptide antibiotics |
| 06/12/2013 | CN103153282A Pharmaceutical dosage form comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine |
| 06/12/2013 | CN103153281A Liquid pharmaceutical composition for the delivery of active ingredients |
| 06/12/2013 | CN103153280A Combinations of hepatitis C virus inhibitors |
| 06/12/2013 | CN103153262A Suction device |
| 06/12/2013 | CN103153261A Oral Film Dosage Form Having Indicia Thereon |
| 06/12/2013 | CN103153045A Compositions for controlling heartworm infestation |
| 06/12/2013 | CN103146668A Preparation technology of lumbrukinase dry powder |
| 06/12/2013 | CN103145968A Folate-conjugated polyethylene glycol monostearate, and preparation method and application thereof |
| 06/12/2013 | CN103145799A Group of polypeptides having percutaneous and transmembrane penetration promoting effect, and applications thereof |
| 06/12/2013 | CN103145776A Gastrodin extraction method, preparation method of gastrodia elata soft capsules and soft capsules obtained by preparation method |
| 06/12/2013 | CN103145736A Medicine composite containing cefamandole nafate compound |
| 06/12/2013 | CN103145713A Doxofylline crystalline compound and lyophilized powder thereof |
| 06/12/2013 | CN103145598A Oxaceprol crystal and composition comprising same |
| 06/12/2013 | CN103145579A Sodium pantothenate compound, and composition preparation containing it |
| 06/12/2013 | CN103143117A Hpyerglycemic foot patch |
| 06/12/2013 | CN103143051A Chitosan chlorhexidine dressing as well as preparation method and use thereof |
| 06/12/2013 | CN103143033A Targeting liver cell carrier and preparation method thereof |
| 06/12/2013 | CN103143029A Coating composition containing cellulose ether with low substitution degree, and film-coated preparation with concealed unpleasant taste |
| 06/12/2013 | CN103143028A Sulfhydrylated amphipathic chitosan polymer carrier as well as preparation method and application thereof |
| 06/12/2013 | CN103143022A Ophthalmologic irrigation solutions and method |
| 06/12/2013 | CN103143019A Compound preparation for treating porcine contagious pleuropneumonia and respiratory tract mixed infection and preparation method thereof |
| 06/12/2013 | CN103143018A Oral formulations containing metformin and alpha-glycosidase inhibitor, and preparation method thereof |
| 06/12/2013 | CN103143007A Method for preparing infectious bursal disease virus live vaccine by utilizing passage chicken embryo fibroblast |
| 06/12/2013 | CN103143001A Bone collagen high calcium tablet |
| 06/12/2013 | CN103143000A Recombinant human interferon alpha2b preparation |